New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents.
نویسندگان
چکیده
Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Clínic, University of Barcelona, Institut d’Investigacions Biomèdiques, Barcelona, Spain. Ester Lozano, PhD; Marta Segarra, PhD; Ana García-Martínez, MD; Georgina Espígol-Frigolé, MD; José Hernández-Rodríguez, MD; Maria C. Cid, MD. This study was supported by the Ministerio de Educación y Ciencia and Fondo Europeo de Desarrollo Regional (FEDER) (SAF 05/06250 and SAF 08/2011) and Marató TV3 (06/0710). G. Espígol-Frigolé and M.C. Cid are supported by the Instituto de Salud Carlos III. Please address correspondence to: Maria C. Cid, MD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Clínic, Villarroel 170, 08036Barcelona, Spain. E-mail: [email protected] Received on June 3, 2008; accepted in revised form on June 21, 2008. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S142-S151. © Copyright CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2008.
منابع مشابه
Histopathologic Features of Giant Cell Arteritis in an Actinic Granuloma Lesion
The association between actinic granuloma and giant cell arteritis (temporal arteritis) has been claimed by some authors. There is a hypothesis that actinic radiation has the principal role in the etiology of both diseases in a similar way. Here, we report a case of actinic granuloma that had characteristic pathologic features of giant cell arteritis in histopathologic examination without clini...
متن کاملGiant cell arteritis: pathogenic mechanisms and new potential therapeutic targets
Giant cell arteritis (GCA) is the most common idiopathic systemic vasculitis in persons aged 50 years or greater. Treatment options for GCA, to-date, have been limited and have consisted primarily of glucocorticoids. Significant advances in the understanding of the genetic and cellular mechanisms in GCA are leading to identification of potential pathogenic targets. The recent success of interle...
متن کاملCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infection
Chronic hepatitis B is still a major public health issue despite the successful prophylactic vaccination attempts. Chronicity of hepatitis B virus(HBV) is mainly due to its ability to debilitate host's immune system. Therefore, major measures have been taken to stop this process and help patients with chronic hepatitis B infection recover from their illness. While satisfactory results have been...
متن کاملThe current status and future of theranostic Copper-64 radiopharmaceuticals
Copper-64 was produced in large scales and high specific activities in late 1990s’ using compact cyclotrons based by 64Ni(p,n)64Cu reaction and many radiopharmaceuticals developed since then by various groups based on interesting physicochemical and nuclear properties of the radionuclide. The unique emission of beta particles as well as positron particles offers a spectacu...
متن کاملTherapeutic metallic ions in bone tissue engineering: A systematic review of the literature
An important field of bone tissue engineering (BTE) concerns the design and fabrication of smart scaffolds capable of inducing cellular interactions and differentiation of osteo-progenitor cells. One of these additives that has gained growing attention is metallic ions as therapeutic agents (MITAs). The specific biological advantage that these ions bring to scaffolds as well as other potential ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical and experimental rheumatology
دوره 26 3 Suppl 49 شماره
صفحات -
تاریخ انتشار 2008